Inactive Instrument

Highlights Wilex AG Deutsche Boerse AG

Equities

DE0006614720

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

04-25	Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
04-23	Transcript : Heidelberg Pharma AG - Special Call

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024	04-25	CI
Heidelberg Pharma AG Reports Earnings Results for the Full Year Ended November 30, 2023	03-25	CI
Heidelberg Pharma Concludes Royalty Purchase Deal with HealthCare Royalty	03-19	MT
Heidelberg Pharma Unit Secures European Patent for Amanitin Toxin-Based Antibody-Drug Conjugates	11-15	MT
Heidelberg Pharma AG Reports Earnings Results for the Nine Months Ended August 31, 2023	12/10/23	CI
Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101	19/09/23	CI
Heidelberg Pharma AG Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	13/07/23	CI
Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 28, 2023	13/04/23	CI
Heidelberg Pharma AG Provides Earnings Guidance for the Year 2023	27/03/23	CI
Heidelberg Pharma AG Reports Earnings Results for the Full Year Ended November 30, 2022	24/03/23	CI
Heidelberg Pharma AG Reports Earnings Results for the Full Year Ended November 30, 2022	24/03/23	CI
Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform	16/12/22	CI
Heidelberg Pharma Ag Announces Encouraging Clinical Data from Two Antibody Drug Conjugates Based on Heidelberg Pharma’s ATAC Technology	13/12/22	CI
Heidelberg Pharma AG Reports Earnings Results for the Nine Months Ended August 31, 2022	13/10/22	CI
Heidelberg Pharma Unit Signs License Deal With Japan's Takeda For Antibody Targeted Amanitin Conjugate	12/09/22	MT
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma	14/07/22	MT
Heidelberg Pharma Enters Research Collaboration Deal With Japan's Chiome Bioscience	13/07/22	MT
Chiome Bioscience Inc. Announces Conclusion of Target-Specific Research and Option Agreement with Heidelberg Pharma	13/07/22	CI
Heidelberg Pharma AG Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	12/07/22	CI
Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 28, 2022	28/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wilex AG Deutsche Boerse AG

Equities

DE0006614720

Highlights

Filters